Theragenics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.10.17	Aider les canadiens à voir clairement après 40 ans (PR Newswire)
02.10.17	S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices (PR Newswire)
26.09.17	RNC Announces Completion of Qiqavik Summer 2017 Gold Exploration Program (PR Newswire)
22.09.17	SS&C GlobeOp Forward Redemption Indicator: September notifications 3.72% (PR Newswire)
13.04.17	Hull Street Energy, LLC Completes Acquisition of Maxim Power (USA) Assets (PR Newswire)
17.10.13	Theragenics Stockholders Approve Merger Deal With Juniper Investment (RTTNews)
05.08.13	Pre-market Movers For Aug 5 (TSN, TGX, CGEN, FB, QCOM) (RTTNews)
05.08.13	Juniper Investment To Buy Theragenics - Quick Facts (RTTNews)
12.06.12	Theragenics® Announces Plans to Repurchase up to $10 Million of Its Shares in a Modified Dutch Auction Tender Offer (Businesswire)
10.05.12	Theragenics® Reports Revenue & Earnings for First Quarter 2012 (Businesswire)
03.05.12	Theragenics Launches Galt Microslide™ Pediatric Introducer Line (Businesswire)
26.04.12	Theragenics Receives FDA Clearance to Market Galt VTI™ Valved Tearaway Introducer (Businesswire)
23.02.12	Theragenics® Reports Revenue & Earnings for Fourth Quarter & Year-End 2011 (Businesswire)
20.02.12	Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base (Businesswire)
14.04.11	Theragenics Signs North American Distribution Agreement with Oncura, a Unit of GE Healthcare (Businesswire)
10.08.10	CDC Corporation Reports Improved Adjusted EBITDA of $9.6 Million in the Second Quarter of 2010 Compared to $8.4 Million in the First Quarter of 2010 (Businesswire)
12.07.10	Theragenics Announces Supply and Reseller Agreement with Oncura (Businesswire)
04.05.10	Acorda Therapeutics Chief Executive Officer Ron Cohen Elected Chairman of BIO Emerging Companies Section (Businesswire)
06.08.09	Theragenics® Reports Revenue & Earnings for Second Quarter 2009 (Businesswire)
28.05.09	Theragenics® Obtains New Credit Agreement (Businesswire)
16.04.09	Theragenics® and Honor Flight Network™ Partner to Assist Veterans and Raise Awareness of Prostate Cancer Treatments (Businesswire)
19.02.09	Theragenics® Reports Record Revenue with 2008 Results (Businesswire)
30.10.08	Theragenics(R) Reports Third Quarter 2008 Results (Businesswire)
16.07.08	Theragenics Agrees to Acquire NeedleTech Products for $47.8 Million (Businesswire)
10.07.08	Theragenics Corporation(R) Engages Men in a National Debate on Prostate Cancer (Businesswire)
20.03.08	Theragenics Corporation(R) Announces Analyst and Investor Meetings and Investor Presentation (Businesswire)
07.02.08	Theragenics(R) Reports Record Annual Revenue with 2007 Results (Businesswire)
28.01.08	Theragenics Corporation(R) Announces Schedule for Fourth Quarter and Year End 2007 Conference Call (Businesswire)
02.08.07	Theragenics(R) Reports Revenue and Earnings for Second Quarter 2007 (Businesswire)
01.11.06	Theragenics(R) Reports Revenue & Earnings for Third Quarter 2006 (Businesswire)
03.08.06	Theragenics(R) Acquires Vascular Access Device Manufacturer; Company Purchases Galt Medical Corp.; Continues Diversification Strategy (Businesswire)
19.07.06	Theragenics(R) Reports Revenue and Earnings for Second Quarter 2006 (Businesswire)
15.05.06	Theragenics Corporation(R) Announces Analyst and Investor Meetings and Investor Presentation (Businesswire)
18.01.06	Theragenics Corporation(R) Reports Fourth Quarter and Year-End 2005 Consolidated Financial Results (Businesswire)
07.03.05	New Peer-Reviewed Study Demonstrates Brachytherapy with Palladium-103 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Theragenics Corp.

Aktien Top/Flop

Meistgelesene Nachrichten